The Efficacy of Adalimumab in Children with Chronic Non-infectious Posterior Uveitis and Panuveitis: A Retrospective Cohort Study.
Tianyu TaoShizhao YangDaquan HeXuening PengZhenyu WangQi JiangTianfu WangWenru SuPublished in: Ophthalmology and therapy (2024)
Adalimumab was effective in the treatment of chronic noninfectious posterior uveitis and panuveitis in pediatric patients, and disease inactivity was accomplished in the majority of the patients, thereby improving visual outcomes and maintaining disease stability. Adverse events were limited and tolerable.
Keyphrases
- juvenile idiopathic arthritis
- end stage renal disease
- rheumatoid arthritis
- newly diagnosed
- ankylosing spondylitis
- ejection fraction
- chronic kidney disease
- young adults
- prognostic factors
- type diabetes
- metabolic syndrome
- patient reported outcomes
- disease activity
- systemic lupus erythematosus
- insulin resistance
- hidradenitis suppurativa